Delivery Order SPE2DB22D2206-SPE2DB25FJD00
Award Date 7/29/25
Potential Completion Date 8/19/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8.55K delivery order to AmerisourceBergen Drug Corp for Mekinist 0.5 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside competitive award was issued on July 23, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mekinist is a targeted cancer therapy medication, reflecting the breadth of pharmaceutical products procured...
- The Defense Logistics Agency awarded a delivery order valued at $11,403.32 to AmerisourceBergen Drug Corp for the supply of Mekinist 0.5 mg tablets (30-count units). The contract, awarded July 21, 2025, carries a firm fixed price and is scheduled for completion by August 11, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,341.02, is for the supply of Mekinist 2 mg tablets to support federal healthcare programs. The contract is a firm fixed-price delivery order with a period of performance through February 27, 2025. It was awarded on February 5, 2025 and does not have a set-aside designation, indicating open...
- This is a $16,564.61 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Mekinist 2 mg tablet. The award is not set aside and is part of AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to supply a wide range of pharmaceutical products and medical supplies to support military and...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,670.51, is for the delivery of Mekinist 2 mg tablets, a prescription medication. The delivery order has a firm fixed price and an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mekinist 2 mg tablets. The $8,878.79 firm-fixed price contract has an ultimate completion date of October 28, 2024. It does not have a set-aside designation. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $8,878.79. The order has a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The contract has a ceiling value of $5,053.45 and a performance period through April 30, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value of $999,999,999.00 and a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,670.51, is for the delivery of the prescription drug Mekinist 2 mg tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of May 21, 2025. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization headquartered in Conshohocken, Pennsylvania. The contract is part of a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $29,011.53 firm fixed price delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...